Treatment for cancer pain

doi:10.1136/bmj.311.7010.951b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

S Ahmedzai,
D J Brooks

Professor CRC lecturer Palliative Medicine Section, Surgical and Anaesthetic Sciences, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF

EDITOR,--Like M Zenz and T Zenz,1 we appreciate the recent paper by Francois Larue and colleagues2 for opening up a discussion on the undertreatment of cancer pain. Perhaps, however, the topic should be referred to as maltreatment of cancer pain.

Zenz and Zenz make the point that legislation for uniformity in the European Union could threaten the freedom to prescribe strong opioids in Britain. The implicit assumption here is that regulation keeps opioid prescribing down and …